These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11093727

  • 1. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion.
    Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Hamamura K, Imai Y, Yoshida H, Shiina S, Omata M.
    Hepatology; 2000 Dec; 32(6):1216-23. PubMed ID: 11093727
    [Abstract] [Full Text] [Related]

  • 2. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [Abstract] [Full Text] [Related]

  • 3. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Lee WJ, Han KH, Chon CY, Kim BR.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [Abstract] [Full Text] [Related]

  • 4. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
    Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF.
    Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
    [Abstract] [Full Text] [Related]

  • 5. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Jul; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 6. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
    Jang JW, Choi JY, Bae SH, Yoon SK, Woo HY, Chang UI, Kim CW, Nam SW, Cho SH, Yang JM, Lee CD.
    Cancer; 2007 Oct 15; 110(8):1760-7. PubMed ID: 17724708
    [Abstract] [Full Text] [Related]

  • 7. Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis.
    Komura T, Mizukoshi E, Kita Y, Sakurai M, Takata Y, Arai K, Yamashita T, Ohta T, Shimizu K, Nakamoto Y, Honda M, Takamura T, Kaneko S.
    Am J Gastroenterol; 2007 Sep 15; 102(9):1939-46. PubMed ID: 17573788
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S.
    J Gastroenterol; 2005 Mar 15; 40(3):274-82. PubMed ID: 15830287
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recurrence of primary hepatocellular carcinoma after hepatectomy--differences related to underlying hepatitis virus species.
    Uchiyama K, Ueno M, Hama T, Kawai M, Tani M, Terasawa H, Ozawa S, Uemura R, Nakase T, Yamaue H.
    Hepatogastroenterology; 2005 Mar 15; 52(62):591-5. PubMed ID: 15816484
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, López-Andujar R, Rayón M, Orbis F, Mora J, De Juan M, Carrasco D, Vila JJ, Prieto M, Berenguer J, Mir J.
    Liver Transpl; 2002 Nov 15; 8(11):1020-7. PubMed ID: 12424715
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY.
    J Hepatol; 2007 Nov 15; 47(5):684-90. PubMed ID: 17854945
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J.
    Cancer; 2013 Jan 01; 119(1):126-35. PubMed ID: 22736338
    [Abstract] [Full Text] [Related]

  • 17. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):459-66. PubMed ID: 17854425
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G.
    Carcinogenesis; 2008 Sep 01; 29(9):1685-91. PubMed ID: 18192693
    [Abstract] [Full Text] [Related]

  • 20. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 01; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.